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Abstract Aims/hypothesis: This systematic review ex-
amines the relationship between alcohol consumption and
long-term complications of type 2 diabetes. Meta-analyses
could only be performed for total mortality, mortality from
CHD, and CHD incidence, because the availability of
articles on other complications was too limited. Materials
and methods: APubMed search through toSeptember 2005
was performed and the reference lists of relevant articles
examined. Among the relevant articles there were six
cohort studies reporting on the risk of total mortality and/or
fatal and/or incident CHD in alcohol non-consumers and in
at least two groups of alcohol consumers. Results: Statis-
tical pooling showed lower risks in alcohol consumers than
in non-consumers (the reference category). The relative risk
(RR) of total mortality was 0.64 (95% CI 0.49–0.82) in the
<6 g/day category. In the higher alcohol consumption
categories (6 to <18, and ≥18 g/day), the RRs of total
mortality were not significant. Risks of fatal and total CHD
were significantly lower in all three categories of alcohol
consumers (<6, 6 to <18 and ≥18 g/day) than in non-
consumers, with RRs ranging from 0.34 to 0.75.
Conclusions/interpretation: This meta-analysis shows
that, as with findings in the general population, moderate
alcohol consumption is associated with a lower risk of
mortality and CHD in type 2 diabetic populations.
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Introduction
It has been convincingly shown that moderate alcohol con-
sumers have an up to 20% lower risk of CHD and mortality
than alcohol non-consumers [1–5]. The mechanisms under-
lying this association are not fully known, but may be related
to beneficial effects on haemostasis and lipidmetabolism [6].
Individuals with type 2 diabetes are at high risk of CHD [7],
and it has been suggested that they may benefit substantially
from moderate alcohol consumption. We have previously
shown that moderate alcohol consumption lowers the risk of
incident type 2 diabetes [8]. However, since alcohol con-
sumption has been associated with increased triglycerides
[6], body weight [9], and blood pressure [10, 11] it may have
adverse consequences for individuals with diabetes. In this
systematic review we examined the relationship between
alcohol consumption and long-term complications of type 2
diabetes. Meta-analyses could only be performed for total
mortality, CHD mortality and CHD incidence, because the
availability of articles on other complications was too
limited.
Materials and methods
Articles included were found through a PubMed search of
literature published until 27 September, 2005. The references
in included articles and relevant reviews [12–17] were
checked for additional studies of interest. Included were
original peer-reviewed publications on observational cohorts
or nested case-control studies in type 2 diabetic populations
L. L. J. Koppes (*) . J. M. Dekker . L. M. Bouter . R. J. Heine
EMGO Institute, VU University Medical Center,
Van der Boechorststraat 7,
1081 BT Amsterdam, the Netherlands
e-mail: l.koppes@vumc.nl
Tel.: +31-204448408
Fax: +31-204448387
L. L. J. Koppes
Department of Public and Occupational Health,
VU University Medical Center,
Amsterdam, the Netherlands
H. F. J. Hendriks
TNO Quality of Life, Department of Physiological Sciences,
Zeist, the Netherlands
R. J. Heine
Department of Endocrinology, VU University Medical Center,
Amsterdam, the Netherlands
Table 1 Included studies and their characteristics
Source Study title Sex At risk
(n)
Follow-up
(years)
Alcohol
use
(g/day)
RR of total
mortality
(95% CI)
RR of CHD
mortality
(95% CI)
RR of incident
CHD
(95% CI)
Valmadrid et al.
1999 [28]
Wisconsin Epide-
miologic
Study of Diabetic
Retinopathy
M &
F
983 12 0.0 1.00 1.00 X
1.0 0.64
(0.48–0.86)
0.54
(0.33–0.90)
7.5 0.47
(0.33–0.69)
0.44
(0.23–0.84)
21.0 0.49
(0.33–0.74)
0.21
(0.09–0.48)
Solomon et al.
2000 [30]
Nurses’ Health
Study
F 5103 14 0.0 X 1.00 1.00
2.5 0.60
(0.36–1.01)
0.72
(0.54–0.96)
10.0 0.38
(0.21–0.67)
14.6 0.43
(0.21–0.88)
22.5 0.56
(0.31–0.99)
Ajani et al.
2000 [29]
Physicians’ Health
Study
M 2790 5.5 0.0 X 1.00 X
0.9 1.11
(0.66–1.89)
6.9 0.67
(0.42–1.07)
18.0 0.42
(0.23–0.77)
510 12 0.0 X X 1.00
0.9 0.84
(0.46–1.54)
6.9 0.75
(0.45–1.26)
18.0 0.66
(0.38–1.16)
Tanasescu et al.
2001 [31]
Health Profes-
sionals
Follow-up Study
M 2419 10 0.0 X 1.00 1.00
3.0 0.79
(0.44–1.41)
0.78
(0.52–1.15)
15.0 0.59
(0.29–1.21)
0.62
(0.38–1.00)
36.0 0.45
(0.17–1.14)
0.48
(0.25–0.94)
de Vegt et al.
2002 [26]
Hoorn Study M &
F
659* 6 0.0 1.00 X X
5.0 0.62
(0.38–1.02)
20.0 0.97
(0.56–1.68)
45.0 1.05
(0.53–2.06)
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on the relationship between alcohol consumption and the
incidence of diabetic complications. Because a non-linear
relationship was presumed, papers were included if a point
estimate and an estimate of variability of the complication
were presented for both alcohol non-consumers and at least
two alcohol consumption categories. In cases where analyses
included more or fewer covariates, those estimates that were
based on the model that included the largest number of
potential confounders were abstracted.
For studies that only reported ranges of alcohol consump-
tion for the categories used, the mean of the lower and upper
limits was used as the average consumption for that range,
and 1.5 times the lower limit was assigned as the average
consumption in the highest category. The averages of the
consumption ranges that were used in a study were assigned
to one of three alcohol categories: zero (reference category),
<6, 6 to <18 and ≥18 g/day. A standard drink contains
approximately 10 g alcohol in Europe/Australia, 12 g in the
USA/Canada, and 21 g in Japan. Pooled relative risk (RR)
estimates were calculatedwithin the three alcohol categories.
More details about the methods used can be found in our
meta-analysis about alcohol consumption and incident type
2 diabetes [8].
Results
Fourteen prospective studies on the relationships between
alcohol consumption and long-term complications of type 2
diabetes were selected on the basis of titles and abstracts of the
467 hits from the PubMed search, and following reference
checking. Four studies were not included because a
dichotomous estimate of alcohol consumption was used
[18–21], one study did not include a category of non-
consumers [22], and one study reported on the score of an
alcoholism screening questionnaire [23]. Of the two publica-
tions from the US Physicians’ Health Study, the one that did
not focus specifically on alcohol consumption was not
included [24]. Only one of the seven remaining publications
involved the incidence and progression of retinopathy [25]. Of
the other six publications (Table 1), three reported the RRs for
total mortality [26–28], five for CHD mortality [27–31], and
three for incident CHD [29–31]. Statistical pooling showed
lower risks for these three outcomes in alcohol consumers as
compared with non-consumers (Fig. 1a–c). For total mortality
the RR was significantly lower in the <6 g/day category only
(RR=0.64, 95% CI 0.49–0.82; Fig. 1a). The risk of CHD
mortality was significantly lower in all three alcohol
consumption categories as compared with the alcohol non-
consumers, andwasmost profound in those consuming≥18 g/
day (Fig. 1b). The RR of incident CHD was significantly
lower in all three drinking categories also (Fig. 1c).
Discussion
To the best of our knowledge, this is the first meta-analysis
on the relationship between alcohol consumption and long-
term disease complications in patients with type 2 diabetes.
Alcohol consumers had a 21–36% lower RR of total
mortality, and a 25–66% lower RR of total and fatal CHD
than non-consumers. These relationships are stronger than
those in the general population where up to 20% lower RRs
are found for moderate drinkers [1–5].
In a study not included but in line with our meta-analysis,
Kuusisto et al. [21] showed non-significant lower RRs of
CHD in type 2 diabetic alcohol consumers than in non-
consumers. However, other studies not included were partly
in contrast with our findings, suggesting an increased risk at
higher consumption levels, as J-shaped relationships were
found between alcohol consumption and the risk of CHD
[22] and acute coronary syndromes [32]. Moreover, alcohol
abuse was also found to be associated with a non-significant
higher risk of CHD [18].
Limited data exist about the relationships of alcohol con-
sumption with other disease complications in type 2 diabetes
Source Study title Sex At risk
(n)
Follow-up
(years)
Alcohol
use
(g/day)
RR of total
mortality
(95% CI)
RR of CHD
mortality
(95% CI)
RR of incident
CHD
(95% CI)
Diem et al.
2003 [27]
Swiss cohort of
WHO
Multinational
Study of
Vascular Disease
in Diabetes
M &
F
287 12.6 0.0 1.00 1.00 X
7.5 1.27
(0.68–2.28)
0.87
(0.25–2.52)
22.5 0.36
(0.09–0.99)
0.01
(0.00–0.92)
45.0 1.66
(0.77–3.33)
0.37
(0.01–2.42)
*Impaired fasting glucose also included in diabetes definition
X No information reported in the publication
Table 1 (continued)
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populations. The Diabetic Impotence Study showed that
type 2 diabetic subjects who consumed more than 33 g
alcohol per day had a higher risk of developing impotence
and retinopathy than those who drank less [19, 20]. In
contrast, Moss et al. [25] found the lowest risks (although not
significant) of incident retinopathy, progression of retinop-
athy, and progression to proliferative retinopathy in their
highest drinking category (>28 g/day). The incidence of
diabetic neuropathywas positively relatedwith higher scores
on an alcoholism screening questionnaire [23], and in regular
heavy drinkers a higher prevalence of symptomatic periph-
eral neuropathy was found [33].
As in the general population [3], the observedmortality risk
reduction related to moderate alcohol consumption in type 2
diabetic subjects could largely be attributed to the reduced risk
of CHD. The beneficial effect of moderate alcohol consump-
tion on markers of inflammation and endothelial dysfunction
[34], on arterial intimal medial thickness [35], pulse wave
velocity [36], HDL cholesterol [6], and insulin sensitivity [37]
may all partly explain the reduced CHD risk. Since these
factors are usually abnormal in individuals with type 2 dia-
betes, their improvement due to alcohol consumption may
explain the larger CHD risk reduction compared with that in
the general population. Alcohol consumption may result
in hypertriglyceridaemia, hypertension and weight gain
in individuals with type 2 diabetes. At moderate levels of
consumption this apparently does not result in a higher
risk of CHD or total mortality.
It should be noted that the number of cases included in this
meta-analysis was relatively small. Because the lowest limit
of the highest drinking category was only 18 g/day, infer-
ences about the effects of heavy drinking by type 2 diabetic
individuals cannot be made from this meta-analysis. How-
ever, some studies identified in our systematic review but not
included in the meta-analyses suggest that heavy drinking
may increase the risk of cardiovascular and other complica-
tions of type 2 diabetes. In conclusion, in line with findings
in the general population, our results indicate that in type 2
diabetic patients moderate consumption of alcohol is
associated with a lower risk of CHD and total mortality.
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